Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.700
-0.060 (-3.41%)
At close: Apr 28, 2026, 4:00 PM EDT
1.730
+0.030 (1.76%)
After-hours: Apr 28, 2026, 6:16 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $106.81 million as of April 28, 2026. Its market cap has increased by 91.14% in one year.
Market Cap
106.81M
Enterprise Value
58.63M
1-Year Change
91.14%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $106.81M, a decrease of -79.61%. That is a compound annual growth rate of -29.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 110.58M | 54.44% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KALA BIO | 126.50M |
| Innate Pharma | 123.03M |
| Verrica Pharmaceuticals | 119.91M |
| Oncolytics Biotech | 119.61M |
| NeOnc Technologies Holdings | 119.08M |
| Aardvark Therapeutics | 117.59M |
| Cardiff Oncology | 117.59M |
| Immunic | 114.82M |